Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

18 projects found matching your search criteria :

  1. Application of probiotic extracellular vesicles in the treatment of chronic wounds with concomitant fungal infection.

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Katarzyna Daria Kowalik

    Uniwersytet Jagielloński

  2. Preparation of pollen-like advanced drug delivery carriers for the treatment of chronic obstructive pulmonary disease

    Call: SHENG 4 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  3. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  4. A machine learning usage to predict venetoclax efficacy and toxicity in chronic lymphocytic leukemia.

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dorota Kruk-Kwapisz

    Warszawski Uniwersytet Medyczny

  5. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  6. Curdlan-based biomaterial as a nanostructure carrier for controlled and targeted drug delivery in the treatment of deep ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: dr Aleksandra Nurzyńska

    Uniwersytet Medyczny w Lublinie

  7. Effect of the chronic treatment with lamotrigine on changes in expression of genes related to seizure processes in the s...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Kinga Katarzyna Borowicz

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

  8. Does myoinositol trispyrophosphate protect against the developement of the right ventricular heart failure in pulmonary ...

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Zuzanna Gabriela Zambrowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  9. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  10. The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

  11. Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen...

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Grażyna Chłoń-Rzepa

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  12. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  13. Evaluation of novel, synergistic drug combinations for the treatment of B cell malignancies

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: dr Małgorzata Firczuk

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  14. Effect of co-treatment with fluoxetine and zinc in a chronic restraint stress (CRS) animal model of depression

    Call: PRELUDIUM 11 , Panel: NZ4

    Principal investigator: Paulina Misztak

    Uniwersytet Jagielloński- Collegium Medicum

  15. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  16. Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Flis

    Narodowy Instytut Leków

  17. Inhibition of activity tryptophan hydroxylase-1 - the new conception in the treatment of mineral and bone disorders in c...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Krystyna Pawlak

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  18. Investigation of the association between IL28-B gene polymorphism and distubances of iron homeostasis in chronic hepatit...

    Call: OPUS 1 , Panel: NZ6

    Principal investigator: dr hab. Katarzyna Teresa Sikorska

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Oddziałem Pielęgniarstwa i Instytutem Medycyny Morskiej i Tropikalnej